Combinatorial treatment using bevacizumab/pemetrexed loaded core-shell silica nanoparticles for non-small cell lung cancer

Dissolution control and stability improvement of silica nanoparticles in aqueous media

(2023) Laura Spitzmüller et al.   JOURNAL OF NANOPARTICLE RESEARCH

Triple Surfactant Assisted Synthesis of Novel Core-shell Mesoporous Silica Nanoparticles with High Surface Area for Drug Delivery for the Prostate Cancer

(2022) Steffi Tiburcius et al.   BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN

Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials

(2022) Kazuki Nozawa et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions

(2022) Panpan Jiang et al.   Immunotherapy

The emergence of nanoporous materials in lung cancer therapy

(2022) Deepika Radhakrishnan et al.   SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

(2021) Jamie E. Chaft et al.   Nature Reviews Clinical Oncology

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC

(2021) Michael J. Grant et al.   Nature Reviews Clinical Oncology

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

(2021) Naoyuki Nogami et al.   Journal of Thoracic Oncology

EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment

(2021) Alex Friedlaender et al.   Nature Reviews Clinical Oncology

An umbrella approach to test lung cancer therapies

(2020) Alexander Drilon et al.   NATURE

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy

(2020) Coral García-Fernández et al.   Cancers

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

(2020) Gary Middleton et al.   NATURE

Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy

(2019) Sitanshu S. Singh et al.   CURRENT MEDICINAL CHEMISTRY

Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction

(2019) Jiamin Rong et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed

(2019) Miroslav Almáši et al.   Materials Science & Engineering C-Materials for Biological Applications

Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect

(2018) Rudra Pangeni et al.   International Journal of Nanomedicine

A Novel Amino and Carboxyl Functionalized Mesoporous Silica as an Efficient Adsorbent for Nickel(II)

(2018) Li Zhang et al.   JOURNAL OF CHEMICAL AND ENGINEERING DATA

Biological therapies in nonsmall cell lung cancer

(2017) Jon Zugazagoitia et al.   EUROPEAN RESPIRATORY JOURNAL

Review of Clay-drug Hybrid Materials for Biomedical Applications: Administration Routes

(2016) Myung Hun Kim et al.   CLAYS AND CLAY MINERALS

Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases

(2016) Dimitra Stefanou et al.   Oncology Letters

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells

(2015) Ying Zhang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway

(2014) Kun-Chieh Chen et al.   PLoS One

Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy

(2014) Shenbagamoorthy Sundarraj et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells

(2014) J Yan et al.   Cell Death & Disease

Silica-based mesoporous nanoparticles for controlled drug delivery

(2013) Sooyeon Kwon et al.   Journal of Tissue Engineering

The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles

(2012) Eleonore Fröhlich   International Journal of Nanomedicine

A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy

(2011) Nam-Hyuk Cho et al.   Nature Nanotechnology

Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution Experience

(2010) Binu Malhotra et al.   Clinical Lung Cancer

Bevacizumab: current indications and future development for management of solid tumors

(2009) Jenia Jenab-Wolcott et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Multiple Core−Shell Functionalized Colloidal Mesoporous Silica Nanoparticles

(2009) Valentina Cauda et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Coupling of soft technology (layer-by-layer assembly) with hard materials (mesoporous solids) to give hierarchic functional structures

(2009) Katsuhiko Ariga et al.   Soft Matter